Healx

The company also said it has received regulatory clearance to start Phase 2 clinical trials for a new drug in the U.S. later this year.

UK-based Ravio reckons real-time data is the best way to arm businesses to win the global talent war. Its new-to-market compensation benchmarking tool lets users see how the compensation (wages…

There are currently no approved cures for Fragile X syndrome — the most common cause of inherited intellectual disability. At the moment, the treatments are designed to manage symptoms, from…

Healx, a Cambridge, U.K.-based startup using AI to help discover new treatments for rare diseases, has raised $56 million in Series B funding. Leading the round is London-base VC firm…